VeriMomБезопасен ли chymotrypsin при беременности?
No harmonised CLP reproductive classification or SCCS/CIR safety assessment was found for chymotrypsin (CAS 9004-07-3), and I found no peer-reviewed reports of developmental or reproductive toxicity from topical exposure. Available regulatory records describe it as an enzyme/protease (use as food enzyme or laboratory reagent) and list respiratory/irritant hazards in some notifications (typical for enzymes) but not reproductive hazards. Sources: ECHA substance/registration pages and EFSA food-enzyme safety review; no CIR/SCCS or harmonised reproductive flags were identified.
Related ingredients
Frequently asked questions
- Безопасен ли chymotrypsin при беременности?
- No harmonised CLP reproductive classification or SCCS/CIR safety assessment was found for chymotrypsin (CAS 9004-07-3), and I found no peer-reviewed reports of developmental or reproductive toxicity from topical exposure. Available regulatory records describe it as an enzyme/protease (use as food enzyme or laboratory reagent) and list respiratory/irritant hazards in some notifications (typical for enzymes) but not reproductive hazards. Sources: ECHA substance/registration pages and EFSA food-enzyme safety review; no CIR/SCCS or harmonised reproductive flags were identified.
- Безопасен ли chymotrypsin при грудном вскармливании?
- No data indicate chymotrypsin is a breastmilk-borne developmental hazard or that topical cosmetic use leads to systemic levels affecting lactation or the nursing infant. Human milk contains endogenous protease inhibitors (including antichymotrypsin), and regulatory reviews (food-enzyme safety) do not report lactation/transfer concerns. Respiratory sensitisation is noted in safety data sheets but does not constitute reproductive/lactation hazard evidence.
- Безопасен ли chymotrypsin для кожи малыша?
- There is no evidence of infant-specific reproductive toxicity. As a protein enzyme, chymotrypsin is a large molecule with very limited dermal bioavailability for intact skin, so adult exposure score is 0; however, by your scoring rules infant skin exposure is increased by +1 because baby skin has a less mature barrier and higher surface-area-to-weight, so baby e = 1. No studies show adverse developmental effects from topical cosmetic use in infants.
- Как VeriMom оценивает chymotrypsin?
- VeriMom оценивает chymotrypsin в 100/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы chymotrypsin при беременности?
- См. наш список безопасных альтернатив chymotrypsin с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.